Alvotech Issues New Shares to Holders of Convertible Bonds

Group 1 - Alvotech issued 22,073,578 new ordinary shares at a fixed price of US$10.00 per share in exchange for subordinated convertible bonds [1] - Following the conversion, the total number of issued shares in Alvotech is 324,801,040, with 301,944,470 outstanding shares [1] - The newly issued shares will be delivered to their owners no later than seven business days from the announcement [1] Group 2 - Alvotech is focused on developing and manufacturing biosimilar medicines, aiming to be a global leader in the biosimilar space [2] - The company has launched two biosimilars and has a development pipeline that includes nine disclosed biosimilar candidates targeting various diseases [2] - Alvotech has established strategic commercial partnerships across multiple regions, including the US, Europe, Japan, and parts of Asia and South America [2]